Immuneering
IMRX
£0.95
Share price
-3.10%
Change (1 day)
-36.10%
Change (1 year)
Categories
Revenue for Immuneering (IMRX)
Revenue in 2024 (TTM): N/A
a decrease over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Immuneering from 2020 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
2024  | N/A | |
| 2023 | N/A | -100% |
| 2022 | £0.26 M | -83% |
| 2021 | £1.54 M | -9.14% |
| 2020 | £1.69 M |